Chronic Liver Disease (CLD): Recent Advances & Key Updates
*
Hello colleagues , Let’s dive into some exciting and clinically relevant updates in the world of Chronic Liver Disease (CLD). Here’s a quick snapshot of recent research (2023-2024) to spark discussion:
Hot Topics in CLD
1. Non-Invasive Biomarkers Take Center Stage
– ELF (Enhanced Liver Fibrosis) test and **FIB-4** are now validated for monitoring fibrosis progression, reducing reliance on liver biopsies.
– New serum markers like **PRO-C3** (a collagen turnover marker) show promise in predicting cirrhosis decompensation.
2. Gut-Liver Axis Breakthroughs
– Dysbiosis in gut microbiota is linked to NAFLD progression and hepatic encephalopathy.
– Trials using probiotics (e.g., Lactobacillus spp.) and FMT (Fecal Microbiota Transplant) are underway to modulate disease outcomes.
3. Antifibrotic Therapies on the Horizon
– Firsocostat (ACC2 inhibitor) and Lanifibranor (pan-PPAR agonist) reduced fibrosis in Phase II trials for NASH.
– Semaglutide (GLP-1 agonist) is now being explored for its anti-inflammatory effects in alcohol-associated liver disease.
4. AI in Hepatology*
– Machine learning models can now predict HCC risk and decompensation events with >85% accuracy using routine clinical data.
5. Compensated Cirrhosis: A Paradigm Shift
– Focus on early surveillance (e.g., annual MR elastography) and lifestyle interventions (low-sodium diets, exercise) to delay decompensation.
**Practice-Changing Guidelines**
-AASLD 2023 Update : Stronger emphasis on screening for metabolic comorbidities in NAFLD patients (e.g., CVD risk assessment).
– EASL Recommendations: Alcohol reduction thresholds revised to <30g/day for men and <20g/day for women in early ALD.
Raiyyan tahsan Date:-10-04-2025 Tuesday Time:-10-05-45 Pm
- TC(1487).(56). General Medicine Department Case No (14): Presumed Treated Hypertension and Type 2 Diabetes with Possible Upper-GI Dyspepsia/Dysmotility and Cardiovascular Risk Management (1 Prescription + 0 Reports + 0 Supporting Images).5432
- TC(1486).(02). Dermatology Department Case No 107:- Suspected Superficial Dermatophytosis with Possible Coexisting Allergic Rhinitis: Clinical Diagnosis, Prescription Analysis and Evidence-Based Management (1PR+0RE+0IMG)4433
- TC(1485).(02). Dermatology Department Case No (106): Undifferentiated Genital Ulcer Disease with Associated Skin Rash and Generalized Weakness Suspected Syphilis versus Genital Herpes; Possible Secondary Bacterial Infection (1 PR+ 0RE + 0Img)7799
- TC(1484).(09).Obstetrics & Gynecology Case No 60:-High-Risk Pregnancy with History of Two Preterm Deliveries and Two Neonatal Deaths: Diagnosis, Drug Safety and Evidence-Based Management(1PR+0RE+0IMG)8090
- TC(1483).(09). Gynecology Department Case No. (59): Physician-Documented Mastitis with Fever — Possible Inflammatory or Bacterial Mastitis; Breast Abscess and Dengue Fever to Be Excluded (1Prescription + 0Reports + 0Images)0909